Clinical trial
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional…
NCT00466063 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00466063 |
|---|---|
| Title | ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox |
| Official title | A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Deferasirox |
| Enrollment | 108 |
| Start date | May 1, 2007 |
| Primary completion | Jul 1, 2015 |
| Completion | Jul 1, 2015 |
| First posted | Apr 27, 2007 |
| Last update posted | Dec 29, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: